Acute Cerebrovascular Disease in the Young
Author:
Rolfs Arndt1, Fazekas Franz1, Grittner Ulrike1, Dichgans Martin1, Martus Peter1, Holzhausen Martin1, Böttcher Tobias1, Heuschmann Peter U.1, Tatlisumak Turgut1, Tanislav Christian1, Jungehulsing Gerhard J.1, Giese Anne-Katrin1, Putaala Jukaa1, Huber Roman1, Bodechtel Ulf1, Lichy Christoph1, Enzinger Christian1, Schmidt Reinhold1, Hennerici Michael G.1, Kaps Manfred1, Kessler Christof1, Lackner Karl1, Paschke Eduard1, Meyer Wolfgang1, Mascher Hermann1, Riess Olaf1, Kolodny Edwin1, Norrving Bo1, Rolfs A2, Ginsberg M3, Hennerici MG4, Kessler C5, Kolodny E6, Martus P7, Norrving B8, Ringelstein EB9, Rothwell PM10, Venables G11, Bornstein N12, deDeyn P13, Dichgans M14, Fazekas F15, Markus H16, Rieß O17, Biedermann C2, Böttcher T2, Brüderlein K2, Burmeister J2, Federow I2, König F2, Makowei G2, Niemann D2, Rolfs A2, Rösner S2, Zielke S2, Grittner U18, Martus P18, Holzhausen M18, Fazekas F19, Enzinger C19, Schmidt R19, Ropele S19, Windisch M20, Sterner E20, Bodamer O21, Fellgiebel A22, Hillen U23, Jonas L24, Kampmann C25, Kropp P26, Lackner K27, Laue M24, Mascher H28, Meyer W29, Paschke E30, Weidemann F31, Berrouschot J32, Stoll A32, Rokicha A32, Sternitzky C32, Thomä M32, DeDeyn PP33, Sheorajpanday R33, De Brabander I33, Yperzeele L33, Brouns R33, Oschmann P34, Pott M34, Schultes K34, Schultze C34, Hirsekorn J34, Jungehulsing GJ35, Villringer A35, Schmidt W35, Liman T35, Nowe T35, Ebinger M35, Wille A35, Loui H35, Objartel A35, übelacker A35, Mette R35, Jegzentis K35, Nabavi DG36, Crome O36, Bahr D36, Ebke M37, Platte B37, Kleinen C37, Mermolja Gunther K37, Heide W38, Pape O38, Hanssen JR38, Stangenberg D38, Klingelhofer J39, Schmidt B39, Schwarz S39, Schwarze J39, Frandlih L39, Iwanow J39, Steinbach I39, Krieger D40, Boysen G40, Leth Jeppesen L40, Petersen A40, Reichmann H41, Becker U41, Dzialkowski I41, Hentschel H41, Lautenschlager C41, Hanso H41, Gahn G41, Ziemssen T41, Fleischer K41, Sehr B41, McCabe DJH42, Tobin O42, Kinsella J42, Murphy RP42, Jander S43, Hartung HP43, Siebler M43, Bottcher C43, Kohne A43, Platzen J43, Brosig TC43, Rothhammer V43, Henseler C43, Neumann-Haefelin T44, Singer OC44, Ermis U44, dos Santos IMRM44, Schuhmann C44, van de Loo S44, Kaps M45, Allendorfer J45, Tanislav C45, Brandtner M45, Muir K46, Dani K46, MacDougall N46, Smith W46, Rowe A46, Welch A46, Fazekas F47, Schrotter G47, Krenn U47, Horner S47, Pendl B47, Pluta-Fuerst A47, Trummer U47, Kessler C48, Chatzopoulos M48, v Sarnowski Bettina48, Schminke Ulf48, Link T48, Khaw A48, Nieber E48, Zierz S49, Muller T49, Wegener N49, Wartenberg K49, Gaul C49, Richter D49, Rosenkranz M50, Krützelmann AC50, Hoppe J50, Choe CU50, Narr S50, Magnus TU50, Thomalla G50, Leypoldt F50, Otto D50, Lichy C51, Hacke W51, Barrows RJ51, Tatlisumak T52, Putaala J52, Curtze S52, Metso M52, Willeit J53, Furtner M53, Spiegel M53, Knoflach MH53, Prantl B53, Witte OW54, Brämer D54, Günther A54, Prell T54, Herzau C54, Aurich K54, Deuschl G55, Wodarg F55, Zimmermann P55, Eschenfelder CC55, Levsen M55, Weber JR56, Marecek SM56, Schneider D57, Michalski D57, Kloppig W57, Küppers-Tiedt L57, Schneider M57, Schulz A57, Matzen P57, Weise C57, Hobohm C57, Meier H57, Langos R57, Urban D57, Gerhardt I57, Thijs V58, Lemmens R58, Marcelis E58, Hulsbosch C58, Aichner F59, Haring HP59, Bach E59, Machado Candido J60, e Silva AA60, Lourenco M60, de Sousa AIM60, Derex L61, Cho TH61, Díez-Tejedor E62, Fuentes B62, Martínez-Sanchez P62, Pérez-Guevara MI62, Hamer H63, Metz A63, Hallenberger K63, Müller P63, Baron P64, Bersano A64, Gattinoni M64, Vella N65, Mallia M65, Jauss M66, Adam L66, Heidler F66, Gube C66, Kiszka M66, Dichgans M67, Karpinska A67, Mewald Y67, Straub V67, Dörr A67, Zollver A67, Ringelstein EB68, Schilling M68, Borchert A68, Preuth N68, Duning T68, Kuhlenbäumer G68, Schulte D68, Rothwell PM69, Marquardt L69, Schlachetzki F70, Boy S70, Mädl J70, Ertl GM70, Fehm NPR70, Stadler C70, Benecke R71, Dudesek A71, Kolbaske S71, Lardurner G72, Sulzer C72, Zerbs A72, Lilek S72, Walleczek AM72, Sinadinowska D72, Janelidze M73, Beridze M73, Lobjanidze N73, Dzagnidze A73, Melms A74, Horber K74, Fink I74, Liske B74, Ludolph AC75, Huber R75, Knauer K75, Hendrich C75, Raubold S75, Czlonkowska A76, Baranowska A76, Blazejewska-Hyzorek B76, Lang W77, Kristoferitsch W77, Ferrari J77, Ulrich E77, Flamm-Horak A77, Lischka-Lindner A77, Schreiber W77, Demarin V78, Tranjec Z78, Bosner-Puretic M78, Jurašić MJ78, Basic Kes V78, Budisic M78, Kopacevic L78
Affiliation:
1. From the Albrecht-Kossel-Institute for Neuroregeneration, University of Rostock, Rostock, Germany (A.R., T.B., A.K.G.); Department of Neurology, University of Graz, Graz, Austria (F.F., C.E., R.S.); Institute for Biostatistics and Clinical Epidemiology, Charite-University Medicine, Berlin, Germany (U.G., P.M., M.H.); Institute for Stroke and Dementia Research and Department of Neurology, Ludwig-Maximillians University, Munich, Germany (M.D.); Center for Stroke Research Berlin,... 2. University of Rostock, Rostock, Germany 3. Miami, Florida 4. Mannheim, Germany 5. Greifswald, Germany 6. New York, New York 7. Berlin, Germany 8. Lund, Sweden 9. Munster, Germany 10. Oxford, UK 11. Sheffield, UK. 12. Tel-Aviv, Israel 13. Middelheim, Belgium 14. Munich, Germany 15. Graz, Austria 16. London, UK 17. Tübingen, Germany 18. Department of Biostatistics and Clinical Epidemiology, Charité - Universitätsmedizin Berlin, Germany 19. Dept of Neurology, Medical University of Graz, Graz, Austria 20. JSW Research Ltd., Graz, Austria 21. (Salzburg, Austria) biochemistry 22. (Mainz, Germany) imaging 23. (Essen, Germany) immunohistochemistry 24. (Rostock, Germany) electron-microscopy 25. (Mainz, Germany) cardiology 26. (Rostock, Germany) headache and pain 27. (Mainz, Germany) biochemistry 28. (Baden, Austria) biochemistry 29. (London) epidemiology and neuropsychiatry 30. (Graz, Austria) biochemistry 31. (Wurzburg, Germany) cardiology 32. Altenburg/Germany 33. Antwerp/Belgium, University 34. Bayreuth/Germany 35. Berlin – Charite/Germany, University 36. Berlin – Neukolln/Germany 37. Bremen/Germany 38. Celle/Germany 39. Chemnitz/Germany 40. Copenhagen/Denmark, University 41. Dresden/Germany, University 42. Dublin/Ireland, University 43. Dusseldorf/Germany, University 44. Frankfurt am Main/Germany, University 45. Giessen/Germany, University 46. Glasgow/United Kingdom, University 47. Graz/Austria, Medical University 48. Greifswald/Germany, University 49. Halle/Germany, University 50. Hamburg/Germany, University 51. Heidelberg/Germany, University 52. Helsinki/Finland, University 53. Innsbruck/Austria, University 54. Jena/Germany, University 55. Kiel/Germany, University 56. Klagenfurt/Austria, University 57. Leipzig/Germany, University 58. Leuven/Belgium, University 59. Linz/Austria, University 60. Lisbon/Portugal, University 61. Lyon/France, University 62. Madrid/Spain, University 63. Marburg/Germany, University 64. Milan/Italy, University 65. Msida/Malta, University 66. Muhlhausen/Thuringen/Germany 67. Munich/Germany, University 68. Munster/Germany, University 69. Oxford/United Kingdom, University 70. Regensburg/Germany, University 71. Rostock/Germany, University 72. Salzburg/Austria, Universit 73. Tbilisi/Georgia, University 74. Tubingen/Germany, University 75. Ulm/Germany, University 76. Warsaw/Poland, University 77. Wien/Austria 78. Zagreb/Croatia, University
Abstract
Background and Purpose—
Strokes have especially devastating implications if they occur early in life; however, only limited information exists on the characteristics of acute cerebrovascular disease in young adults. Although risk factors and manifestation of atherosclerosis are commonly associated with stroke in the elderly, recent data suggests different causes for stroke in the young. We initiated the prospective, multinational European study Stroke in Young Fabry Patients (sifap) to characterize a cohort of young stroke patients.
Methods—
Overall, 5023 patients aged 18 to 55 years with the diagnosis of ischemic stroke (3396), hemorrhagic stroke (271), transient ischemic attack (1071) were enrolled in 15 European countries and 47 centers between April 2007 and January 2010 undergoing a detailed, standardized, clinical, laboratory, and radiological protocol.
Results—
Median age in the overall cohort was 46 years. Definite Fabry disease was diagnosed in 0.5% (95% confidence interval, 0.4%–0.8%; n=27) of all patients; and probable Fabry disease in additional 18 patients. Males dominated the study population (2962/59%) whereas females outnumbered men (65.3%) among the youngest patients (18–24 years). About 80.5% of the patients had a first stroke. Silent infarcts on magnetic resonance imaging were seen in 20% of patients with a first-ever stroke, and in 11.4% of patients with transient ischemic attack and no history of a previous cerebrovascular event. The most common causes of ischemic stroke were large artery atherosclerosis (18.6%) and dissection (9.9%).
Conclusions—
Definite Fabry disease occurs in 0.5% and probable Fabry disease in further 0.4% of young stroke patients. Silent infarcts, white matter intensities, and classical risk factors were highly prevalent, emphasizing the need for new early preventive strategies.
Clinical Trial Registration Information—
URL:
http://www.clinicaltrials.gov
.Unique identifier: NCT00414583
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Advanced and Specialised Nursing,Cardiology and Cardiovascular Medicine,Clinical Neurology
Cited by
195 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|